Form 4 filings across 4 companies. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: +$1M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 4 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 13 most recent Form 4 transactions.
| Dyne Therapeutics, Inc. |
| AGRANT◆ |
| 35,152 |
| — |
| — |
| — |
| Open the original filing on SEC.gov |
| Jun 2 | CBIO | Crescent Biopharma, INC. | AGRANT◆ | 11,050 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 9,174 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 8,011 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 11,459 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 61,538 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 31,794 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 59,405 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | DTOISS◆ | 13,626 | — | — | — | Open the original filing on SEC.gov |
| Apr 28 | ACLX | Arcellx, Inc. | UTENDR | 21,659 | — | — | -100.0% | Open the original filing on SEC.gov |
| Apr 24 | DYN | Dyne Therapeutics, Inc. | GGIFT | 53,625 | — | — | -100.0% | Open the original filing on SEC.gov |